Interestingly, enhancing the BCL‐2 expression in SH‐SY5Y cells using an anti‐PD drug called rasagiline has shown promising results in protecting neuronal degeneration in PD (Akao et al., 2002). This evidence concerns the gene BCL2 and Parkinson disease.